Frontiers | HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy | Immunology
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes | PNAS
Chapter 10: Human Leucocyte Antigen (HLA), Major Histocompatibility complex (MHC) - Labpedia.net
Introduction to Flow Cytometric Analysis | Flow Cytometry
Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
HLA LOH Monitoring — JETA Molecular
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases
Human leukocyte antigen - Wikipedia
Expression of the T cell activation markers HLA-DR and CD38 on... | Download Scientific Diagram
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study | Stem Cell Research & Therapy | Full Text
HLA typing in cancer
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
HLA Matching, Antibodies, and You
Frontiers | Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types | Immunology
Molecular Pathways: Human Leukocyte Antigen G (HLA-G) | Clinical Cancer Research
Cancers | Free Full-Text | HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
PLOS ONE: Influence of surface geometry on the culture of human cell lines: A comparative study using flat, round-bottom and v-shaped 96 well plates